Drug Name: | Flurbiprofen (5104-49-4) |
---|---|
PubChem ID: | 3394 |
SMILES: | CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O |
InchiKey: | SYTBZMRGLBWNTM-UHFFFAOYSA-N |
Therapeutic Category: | Analgesics, Anti-Inflammatory Agents, Antirheumatic Agents, Central Nervous System Agents, Cyclooxygenase Inhibitors, Enzyme Inhibitors, Peripheral Nervous System Agents, Sensory System Agents |
Molecular Weight (dalton) | : | 244.265 |
LogP | : | 3.6808 |
Ring Count | : | 2 |
Hydrogen Bond Acceptor Count | : | 1 |
Hydrogen Bond Donor Count | : | 1 |
Total Polar Surface Area | : | 37.3 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Methotrexate (59-05-2) | Haematemesis | Synergistic | The NSAIDs as a group inhibit the synthesis of the prostaglandins (PGE2) resulting in a fall in renal perfusion, which could lead to a rise in serum methotrexate levels | Methotrexate and nonsteroidal antiinflammatory drug interactions |
Methotrexate (59-05-2) | Neutropenia | Synergistic | The NSAIDs as a group inhibit the synthesis of the prostaglandins (PGE2) resulting in a fall in renal perfusion, which could lead to a rise in serum methotrexate levels | Methotrexate and nonsteroidal antiinflammatory drug interactions |
Methotrexate (59-05-2) | Thrombocytopenia | Synergistic | The NSAIDs as a group inhibit the synthesis of the prostaglandins (PGE2) resulting in a fall in renal perfusion, which could lead to a rise in serum methotrexate levels | Methotrexate and nonsteroidal antiinflammatory drug interactions |
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category